Journal of Infection and Chemotherapy

SJR Rank #11,834H-index: 79SJR: 0.503Best quartile: Q3APC: US$2,650
Journal website: aims, scope and author guidelines
Publisher

Elsevier B.V.

Country

Netherlands

Type

journal

SJR by Edition

2022202500.150.30.450.6

Subject Categories

  • Infectious DiseasesQ3
  • Microbiology (medical)Q3
  • Pharmacology (medical)Q3

Areas: Medicine

Most published research topics

Pneumonia and Respiratory InfectionsAntibiotic Resistance in BacteriaAntimicrobial Resistance in StaphylococcusAntibiotics Pharmacokinetics and EfficacyBacterial Identification and Susceptibility TestingStreptococcal Infections and TreatmentsAntifungal resistance and susceptibilityRespiratory viral infections researchUrinary Tract Infections ManagementBacterial Infections and Vaccines

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0200400600800

Documents per Year

202220250100200300400

Detailed Information

ISSN

1437-7780, 1341-321X

SJR Best Quartile

Q3

Region

Western Europe

Citations per Document (2 years)

1.66

References per Document

26.52

Coverage

1995-2026

Scope

The Journal of Infection and Chemotherapy (JIC) — official journal of the Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases — welcomes original papers, laboratory or clinical, as well as case reports, notes, committee reports, surveillance and guidelines from all parts of the world on all aspects of chemotherapy, covering the pathogenesis, diagnosis, treatment, and control of infection, including treatment with anticancer drugs. Experimental studies on animal models and pharmacokinetics, and reports on epidemiology and clinical trials are particularly welcome.

Metrics from SCImago Journal Rank 2025. View on SCImago